Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Sep 28 1999
WASHINGTON, D.C. (Sept. 28, 1999) - The BiotechnologyIndustry Organization (BIO) announced today South Carolina has become the 26th state to form an...
Sep 23 1999
WASHINGTON, D.C. -- The Biotechnology Industry Organization (BIO) today applauded Sen. Orrin Hatch (R-Utah) for his introduction of the Medicare Patient Access...
Sep 23 1999
WASHINGTON, D.C. (Sept. 23, 1999) The Biotechnology Industry Organization (BIO) strongly opposed a bill introduced today by U.S. Rep. Sherrod Brown (D-Ohio),...
Sep 23 1999
WASHINGTON, D.C. (Sept. 23, 1999) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), today issued the following statement on the...
Sep 21 1999
"Biotech Works" Theme Will Attract 7,000 from Around the World WASHINGTON, D.C. (September 21, 1999) Boston will get its first opportunity to host...
Aug 20 1999
WASHINGTON, D.C. (August 20, 1999) --The Biotechnology Industry Organization (BIO) has launched its second series of radio ads aimed at focusing President...
Aug 12 1999
WASHINGTON (Aug. 12, 1999) -- An expert panel of university and independent researchers, entomologists and weed scientists is currently conducting studies to...
Aug 5 1999
Washington, D.C. (August 4, 1999) -- In response to a study by University of Arizona entomologists appearing in the scientific correspondence of the Aug. 5...
Aug 4 1999
WASHINGTON, D.C. (August 4, 1999) The Biotechnology Industry Organization (BIO) today applauded the U.S. House for its overwhelming approval of a bill that...


Biotechnology News

September 1, 2014

RYDALMERE, Australia--(BUSINESS WIRE)--Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced...

September 1, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial...

September 1, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass, founder and...

September 1, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of...

September 1, 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (...